Dendreon Stock/Option Volume Analysis (DNDN)
By now you know the news for Dendreon Corporation (NASDAQ: DNDN). It turns out that the pre-event snapshot gave a very close and accurate read on what to expect from the volatility trade in options ahead of PROVENGE getting FDA approval. And this morning shares hit yet a new high of $55.00. At 10:50 AM [...]
VS Investor RSS Feed